International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1 Trial
Titel:
International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1 Trial
Auteur:
Trappe, R.U. Choquet, S. Dierickx, D. Mollee, P. Zaucha, J.M. Dreyling, M.H. Dührsen, U. Tarella, C. Shpilberg, O. Sender, M. Salles, G. Morschhauser, F. Jaccard, A. Lamy, T. Reinke, P. Neuhaus, R. Lehmkuhl, H. Horst, H.A. Leithäuser, M. Schlattmann, P. Anagnostopoulos, I. Raphael, M. Riess, H. Leblond, V. Oertel, S.
Verschenen in:
American journal of transplantation
Paginering:
Jaargang 15 () nr. 4 pagina's 1091-1100
Jaar:
2015
Inhoud:
Uitgever:
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.